BrainStorm Cell Therapeutics Summarizes Key Messages from Its Participation as Expert Speakers in an Invited Presentation and Panel Discussion at The 2023 ALS Drug Development Summit

– Presentation by Co-CEO Stacy Lindborg, Ph.D., held at 2023 ALS Drug Development Summit – Summit Focused On Transforming Translational Tools to Accelerate Future ALS Approvals NEW YORK, May 19, 2023 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of…

Leave a Reply

Your email address will not be published. Required fields are marked *